Non-instrumentation Root Canal Treatment of Primary Molars

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-04

Study Completion Date

2025-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical trial intended to evaluate the efficacy of a technique of root canal treatment of deciduous molars with non-instrumentation of root canals and use of a paste containing antibiotics (chloramphenicol and tetracycline) and zinc oxide and eugenol (CTZ group). The hypothesis is that the efficacy of non-instrumentation treatment is non-inferior than the standard treatment involving manual instrumentation of root canals and filling with zinc oxide and eugenol paste (ZOE group) after 24 months of follow-up. Children will be randomly allocated to one of the two groups: CTZ group or ZOE group. In the CTZ group, after the location of root canals entrance, an initial irrigation will be conducted using 1% sodium hypochlorite. Then, CTZ paste will be placed in the pulp chamber floor, over the root canal entrances. The instrumentation of the root canals will not be performed for children allocated to this group. For the ZOE group, manual instrumentation with endodontic K files will be performed, aided by irrigation with 1% sodium hypochlorite. After the end of the instrumentation, root canals will be filled with ZOE paste. All teeth will be restored with bulk-fil resin composite. Children will be followed-up for 6, 12, 18 and 24 months after the treatment. The primary endpoint will be the success of endodontic treatment evaluated by clinical and radiographic methods after 24 months. Based on a non-inferiority limit of 15% in the success rate, an anticipated sample size of 218 (109 per group) was estimated, divided among the centers. This sample size was further corrected two times (due to slower-than-anticipated recruitment, and due to the drop of a center participant of the study), reaching a required minimum sample size of 182 participants (91 participants per group).

Other secondary endpoints will be clinical time spent with the treatments, children's behavior during the treatment, discomfort immediately after the end of the treatment reported by the children, post-operative pain, improvement in the negative impact of Oral Health-Related Quality of Life, costs and cost-efficacy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Root Canal Treatment in Primary Molars With Necrotic Pulp Using Two Different Pulp Therapies

NCT03650036

Dental Pulp Necrosis

COMPLETED PHASE2

Antimicrobial Pulpotomy of Primary Molars

NCT01010451

Inflammation Necrosis

COMPLETED PHASE4

Lesion Sterilization And Tissue Repair Versus Zinc Oxide And Eugenol For Treatment of Necrotic Primary Molars

NCT05448937

Necrotic Primary Molars

COMPLETED PHASE2/PHASE3

Endodontic Treatment Using CTZ Paste in Primary Teeth

NCT03731975

Pulpectomy Agents

UNKNOWN NA

Efficacy of Guedes-Pinto Paste and CTZ Paste in the Non-instrumental Endodontic Treatment of Primary Teeth

NCT04587089

Necrotic Pulp

UNKNOWN PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Most techniques for endodontic treatment in primary teeth require instrumentation of root canals and filling with an absorbable paste. This filling material could be pastes based on zinc oxide and eugenol, calcium hydroxide or iodoform, or filling materials composed by mixture of some of these components. This method, however, requires a long clinical time, which can be a challenge in the Pediatric Dentistry clinical practice. Therefore, some alternative techniques in which non-instrumentation is necessary have been purposed.

The non-instrumentation technique most used in Brazil is a technique previously described, in 1964. This method involves the access to pulp chamber and removal of necrotic tissue with irrigation. After that, with no instrumentation of the root canals, a medicament containing zinc oxide and eugenol and two antibiotics, chloramphenicol and tetracycline, is placed in the entrance of the canals, and the restoration of the teeth is performed. Although the non-instrumentation methods for endodontic treatment of primary teeth are attractive and demand a short clinical time, strong evidence from well-conducted clinical trial lacks.

Therefore, this four-center parallel-arms non-inferiority randomized clinical trial was designed to evaluate the efficacy of a non-instrumentation of root canals and use of a paste containing antibiotics (chloramphenicol and tetracycline) and zinc oxide and eugenol (CTZ) technique for endodontic treatment of primary molars. The hypothesis is that the efficacy of non-instrumentation treatment is non-inferior to the standard treatment involving manual instrumentation of root canals and filling with zinc oxide and eugenol (ZOE) paste after 24 months of follow-up. Children who look for dental treatment in one of four participating centers and who have at least one primary molar requiring endodontic treatment will be eligible. If the child has more than one molar with pulp involvement, the included tooth will be determined by chance. Other teeth will be treated, but they will not be included in the study. The participating centers are the dental schools of Santa Catarina Federal University, University of Sao Paulo, Rio de Janeiro State University and Iguaçu University. Included children will be randomly allocated to one of the two groups (allocation ratio of 1:1): CTZ group (non-instrumentation technique) and ZOE group (standard treatment).

Randomization list will be generated in an appropriate website (www.sealedenvelopes.com), in permuted blocks (2, 4, and 8 samples) and stratified for the center. The sequence will be enclosed in individual opaque envelopes separated by the stratum. The disclosure of the allocated group will occur when the children will be seated in the dental chair, after the anesthesia, rubber dam isolation and opening of the tooth included for that child. Than the included tooth will be allocated to the CTZ group or to ZOE group. After the treatment, children will be followed-up for 6, 12, 18 and 24 months. Evidence of treatment failure in any period will be recorded, and the teeth will be extracted.

The primary endpoint will be the success of the dental treatment after 24 months of follow-up (teeth with no evidence of failure in all follow-ups). The sample size calculation was estimated based on a success rate of 92% obtained in pulpectomies using ZOE from a previous systematic review (Coll et al., 2020), a non-inferiority limit of 15%, a significance level of 5% and statistical power of 90%. It was added 20% to this number to contemplate possible drop-outs and 60% due to the multi-center design. The anticipated sample size was 218 teeth (109 per group), divided among the centers.

However, in March 2023, we decided to modify the original sample size from 218 to 200 participants, due to slower-than-anticipated recruitment. With this sample, considering the same parameters, we maintained a statistical power of around 90% (90.6%).

Another problem we have noticed in the last year (between March 2024 and March 2025) is that one of the study centers (Iguaçu University) was unable to include and follow up an adequate number of participants (less than 10 children in almost two years). Therefore, we decided to drop this center, and we recalculated the sample size, adjusting the correction for the multicenter design to 1.4. Our final minimum sample size to reach an adequate power, considering the prespecified parameters - 5% of significance level, 90% of statistical power, 92% of success rate for the control group, a non-inferiority limit of 15% and adding 60% to this number (20% for drop-outs and 40% due to multicenter design) - was 182 participants. As our randomization process was stratified per center, we do not expect a significant bias due to the center drop.

Masking will not be possible for participants, operators, researchers, or even outcome assessors due to the different nature of the treatments. However, the outcome assessor will not be informed of the allocated group for each tooth.

Other secondary endpoints will be the clinical time spent with the treatments, children's behavior during the treatment, discomfort immediately after the end of the treatment reported by the children, post-operative pain, short- and long-term improvement in the negative impact of Oral Health-Related Quality of Life, costs and cost-efficacy. The frequency of treatment success after 24 months will be compared between the groups in the intention-to-treat population considering the non-inferiority limit of 15% by the Miettinen-Nurminen's method. Sensitivity analysis will be conducted through non-inferiority Cox regression. For this, the period that the treatment failure occurred will be recorded. Secondary outcomes will be compared by proper statistical tests considering two-tailed hypothesis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dental Pulp Diseases Dental Pulp Necrosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Multi-center, open label, non-inferiority randomized controlled trial

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CTZ group

Non-instrumentation endodontic treatment and use of a paste containing two antibiotics (chloramphenicol and tetracycline) and zinc oxide and eugenol (CTZ paste)

Group Type EXPERIMENTAL

Non-instrumentation technique with use of CTZ paste

Intervention Type PROCEDURE

After local anesthesia and rubber dam isolation, the pulp chamber will be accessed. After the location of root canals entrance, an initial irrigation will be conducted using 1% sodium hypochlorite. Then, a paste containing two antibiotics (chloramphenicol and tetracycline) and zinc oxide and eugenol (CTZ paste) will be placed in the pulp chamber floor, into the root canal entrances. Then, a layer of glass ionomer cement will be placed, and the teeth will be restored with bulk-fil resin composite.

ZOE group

Endodontic treatment with instrumentation and filling with Zinc Oxide and Eugenol paste (ZOE paste)

Group Type ACTIVE_COMPARATOR

Instrumentation technique and filling with Zinc Oxide and Eugenol paste

Intervention Type PROCEDURE

After anesthesia and rubber dam isolation, pulp chamber will be accessed with burs, and the root canals entrance will be prepared using a Gates Glidden bur. The root canal length determination will be done subtracting 1 mm from the radiographic measurements performed on the different roots. The instrumentation will be performed with 21mm stainless steel endodontic hand K-files, with International Organization for Standardization (ISO) tip ranging from #08 to #35. Irrigation will be performed using 1% sodium hypochlorite. After the last file, a final irrigation will be conducted with ethylenediaminetetraacetic acid and tegentol (EDTA-T) and 0.9% sodium chloride solution, and the root canals will be dried with paper points. Then, the root canals will be filled with a Zinc Oxide and Eugenol paste (ZOE paste), inserted into the root canals with a lentulo spiral. A layer of glass ionomer cement will be placed, and the teeth will be restored with bulk-fil resin composite.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-instrumentation technique with use of CTZ paste

After local anesthesia and rubber dam isolation, the pulp chamber will be accessed. After the location of root canals entrance, an initial irrigation will be conducted using 1% sodium hypochlorite. Then, a paste containing two antibiotics (chloramphenicol and tetracycline) and zinc oxide and eugenol (CTZ paste) will be placed in the pulp chamber floor, into the root canal entrances. Then, a layer of glass ionomer cement will be placed, and the teeth will be restored with bulk-fil resin composite.

Intervention Type PROCEDURE

Instrumentation technique and filling with Zinc Oxide and Eugenol paste

After anesthesia and rubber dam isolation, pulp chamber will be accessed with burs, and the root canals entrance will be prepared using a Gates Glidden bur. The root canal length determination will be done subtracting 1 mm from the radiographic measurements performed on the different roots. The instrumentation will be performed with 21mm stainless steel endodontic hand K-files, with International Organization for Standardization (ISO) tip ranging from #08 to #35. Irrigation will be performed using 1% sodium hypochlorite. After the last file, a final irrigation will be conducted with ethylenediaminetetraacetic acid and tegentol (EDTA-T) and 0.9% sodium chloride solution, and the root canals will be dried with paper points. Then, the root canals will be filled with a Zinc Oxide and Eugenol paste (ZOE paste), inserted into the root canals with a lentulo spiral. A layer of glass ionomer cement will be placed, and the teeth will be restored with bulk-fil resin composite.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children who look for dental treatment
* Children with at least one primary molar with clinical and/or radiographic signs of pulpal involvement
* Formal consent of the children's parents or legal guardians agreeing with the participation of the children
* Write or verbal assent of the children in participating of the study

Exclusion Criteria

* Children with special needs
* Children with report of allergy to the medications used in the pastes
* Children with a negative behavior in the inclusion session

Minimum Eligible Age

3 Years

Maximum Eligible Age

9 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No